Ardelyx (ARDX) EBIT Margin Growth (3y) (2018 - 2026)
Ardelyx (ARDX) EBIT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 19,454.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,454.00 |
| Dec 31, 2025 | -2,341.00 |
| Sep 30, 2025 | 57,612.00 |
| Jun 30, 2025 | 102,307.00 |
| Mar 31, 2025 | 589,262.00 |
| Dec 31, 2024 | 343,489.00 |
| Sep 30, 2024 | 360,295.00 |
| Jun 30, 2024 | 339,586.00 |
| Mar 31, 2024 | 43,263.00 |
| Dec 31, 2023 | 144,664.00 |
| Sep 30, 2023 | 64,567.00 |
| Jun 30, 2023 | 124,403.00 |
| Mar 31, 2023 | 156,539.00 |
| Dec 31, 2022 | 86,518.00 |
| Sep 30, 2022 | 29,429.00 |
| Jun 30, 2022 | 13.69 Mn |
| Dec 31, 2021 | 2.88 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 7.04 Mn |
| Mar 31, 2021 | 27,603.00 |